Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster

Published on: 

Applied Clinical Trials

Symbio LLC has announced the signing of a five-year contract with OmniComm Systems, Inc., to use their TrialMaster version 5 to develop and manage clinical study databases.  

For more information, click here.